Two-year Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity
Clinical trial NCT03693430 · COMPLETED
Trial details
- NCT number
- NCT03693430
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-05
- Primary completion
- 2021-01-29
- Enrollment
- 304
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.